Bioventus (NASDAQ:BVS) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.02 by 300 percent. This is a 14.29 percent increase over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $123.88 million which beat the analyst consensus estimate of $122.70 million by 0.96 percent. This is a 4.31 percent decrease over sales of $129.46 million the same period last year.